Diagnosis and Management of Heart Failure |
Autore | Gladysheva Inna P |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (202 p.) |
Soggetto topico |
Medicine
Cardiovascular medicine |
Soggetto non controllato |
biomarkers
ST-segment elevation myocardial infarction preserved left ventricular ejection fraction reduced left ventricular ejection fraction heart failure NT-proBNP soluble ST2 galectin-3 matrix metalloproteinases tissue inhibitors of metalloproteinases mortality ejection fraction cardiopulmonary exercise test ventilatory inefficiency angiotensin receptor-neprilysin inhibitor echocardiography HFrEF risk stratification left ventricle end-diastolic diameter E/e' ratio left ventricle outflow tract velocity-time integral hospitalization predictor short-term prognosis heart failure readmission acute myocardial infarction blood biomarkers diagnosis congestion clinical assessment preserved ejection fraction type 2 diabetes mellitus myocardial infarction chronic heart failure heart rate variability 2D echocardiography 24-h ECG monitoring chronic kidney disease pulmonary hypertension arteriovenous fistulas overhydration heart transplant cardiac allograft vasculopathy heart transplant rejection transthoracic echocardiography longitudinal strain sensing parameters pacing parameters adverse left ventricular remodeling left ventricular-arterial coupling fatty liver cardiovascular disease fibrosis epicardial fat left atrial strain edema dilated cardiomyopathy fluid management endothelial dysfunction |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910576881803321 |
Gladysheva Inna P | ||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Novel Biomarkers for Heart Disease |
Autore | Lichtenauer Michael |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (420 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
diet quality
ceramides obesity cardiovascular risk healthy eating index carbohydrate antigen-125 heart failure inflammatory marker older women biomarker cardiometabolic disease epicardial adipose tissue epicardial fat epicardial fat volume microRNA thyroid-stimulating hormone cardiometabolic risks metabolic syndrome hypertension very low-density lipoprotein STIM1 SOCE atrial myopathy atrial fibrillation ejection fraction soluble urokinase-type plasminogen activator receptor (suPAR) growth differentiation factor 15 (GDF-15) heart-type fatty acid-binding protein (H-FABP) soluble suppression of tumorigenicity 2 (sST2) acute myocardial infarction biomarkers catestatin coronary artery disease heart failure decompensation left ventricular ejection fraction troponin NT-proBNP NYHA functional class GDF-15 cardiovascular surgery operative risk muscle wasting sarcopenia renal dysfunction chronic kidney disease aortic disease aneurysm miRNA TGF-β pathway KLF4 synthetic phenotype aortic regurgitation echocardiography magnetic resonance imaging vena contracta area longitudinal strain T1 mapping GDF8 myostatin AMI ceruloplasmin H-FABP heart-type fatty acid-binding protein FABP3 fatty acid-binding protein 3 HF cardiac biomarkers cardiac magnetic resonance imaging left ventricular systolic function magnetic resonance spectroscopy myocardial triglyceride content cell adhesion molecule repeated measurements pregnancy-associated plasma protein-A cohort studies cardiovascular diseases mitochondrial dysfunction circulating cells PBMCS platelets oxidative stress reactive oxygen species (ROS) mitochondrial DNA (mtDNA) herat failure liver-type fatty-acid-binding protein long-term outcomes cardiac intensive care units acute kidney injury myocardial infarction STEMI cardiovascular events cardiovascular death risk stratification sST2 Pentraxin-3 sudden cardiac death ventricular arrhythmia ventricular tachycardia chronic heart failure saliva salivary biomarkers CKD CVD PPCI left ventricular adverse remodelling circulating miRNAs NAFLD Framingham risk score risk prediction secondary prevention primary prevention NAFLD fibrosis score HFpEF HFrEF suPAR |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557546203321 |
Lichtenauer Michael | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|